CSPC Pharmaceutical Group Limited (CSPCY)

USD 2.94

(13.08%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 46.28 Billion 41.76 Billion 34.74 Billion 30.07 Billion 26.31 Billion 22.69 Billion
Total Current Assets 26.74 Billion 23.95 Billion 20.33 Billion 15.92 Billion 13.69 Billion 13.77 Billion
Cash And Short Term Investments 13.09 Billion 13.87 Billion 10.72 Billion 8.79 Billion 5.95 Billion 6.61 Billion
Cash and Cash Equivalents 12.01 Billion 10.29 Billion 9.28 Billion 7.25 Billion 4.11 Billion 4.32 Billion
Short Term Investments 1.07 Billion 3.57 Billion 1.44 Billion 1.53 Billion 1.83 Billion 2.28 Billion
Net Receivables 10.68 Billion 7.62 Billion 7.98 Billion 5.38 Billion 4.91 Billion -
Inventory 3.13 Billion 2.55 Billion 2.48 Billion 1.86 Billion 2.53 Billion 3.03 Billion
Other Current Assets 142.5 Million 113.22 Million 49.29 Million 251.9 Million 1.12 Billion -
Total Non-Current Assets 19.53 Billion 17.81 Billion 14.4 Billion 14.14 Billion 12.62 Billion 9.39 Billion
Net PPE 11.64 Billion 10.97 Billion 9.56 Billion 8.93 Billion 9.28 Billion 7.2 Billion
Good Will And Intangible Assets 2.43 Billion 2.14 Billion 617.83 Million 658.72 Million 1.32 Billion 945.86 Million
Good Will 234.9 Million 234.9 Million 149.98 Million 149.98 Million 188.96 Million 140.47 Million
Intangible Assets 2.19 Billion 1.9 Billion 467.85 Million 508.74 Million 1.13 Billion 805.38 Million
Long-Term Investments 5.05 Billion 145.48 Million 1.87 Billion 1.6 Billion -352.98 Million -
Tax Assets 186.77 Million 113.02 Million 43 Million 117.47 Million 34.84 Million -
Other Non Current Assets 218.32 Million 4.43 Billion 2.3 Billion 2.83 Billion 2.33 Billion 1.24 Billion
Other Assets - - - - - -476.39 Million
Total Liabilities 11.26 Billion 10.12 Billion 7.91 Billion 6.96 Billion 6.8 Billion 7.67 Billion
Total Current Liabilities 10.18 Billion 8.95 Billion 7.22 Billion 6.3 Billion 6.23 Billion 7.23 Billion
Account Payables 2.84 Billion 2.01 Billion 1.62 Billion 1.24 Billion 1.42 Billion 3.26 Billion
Tax Payables 560.95 Million 442.84 Million 363.23 Million 510.13 Million 258.82 Million -
Short Term Debt 599.84 Million 295.55 Million 38.42 Million 223.83 Million 97.23 Million -
Deferred Revenue -839.62 Million - - - - -
Other Current Liabilities 7.58 Billion 6.65 Billion 5.56 Billion 4.83 Billion 4.71 Billion 3.96 Billion
Total Non Current Liabilities 1.08 Billion 1.16 Billion 687.3 Million 667.29 Million 563.38 Million 439.34 Million
Long-Term Debt 107.05 Million 286.98 Million 55.62 Million 92.87 Million 90.3 Million -
Deferred Revenue Non Current -672.42 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.07 Billion 270.91 Million 250.19 Million 253.96 Million 168.65 Million 201.9 Million
Other Liabilities - - - - - 1.00
Total Equity 35.01 Billion 31.64 Billion 26.82 Billion 23.1 Billion 19.51 Billion 15.02 Billion
Stock Holders Equity 33.2 Billion 30.19 Billion 25.98 Billion 22.33 Billion 18.46 Billion 15.02 Billion
Common Stock 10.89 Billion 10.89 Billion 10.89 Billion 10.89 Billion 10.89 Billion -
Retained Earnings 24.03 Billion 21.13 Billion 17.27 Billion 18.04 Billion 12.86 Billion -
Accumulated other comprehensive income 24.53 Billion -4.53 Billion -4.98 Billion -4.4 Billion -4.33 Billion -
Common Stock Equity 33.2 Billion 30.19 Billion 25.98 Billion 22.33 Billion 18.46 Billion 15.02 Billion
Capital Lease Obligation 256.68 Million 400.11 Million 94.04 Million 217.71 Million 164.53 Million -
Total Investments 4.59 Billion 3.72 Billion 3.32 Billion 3.14 Billion 1.48 Billion 2.28 Billion
Total Debt 706.9 Million 582.54 Million 94.04 Million 316.71 Million 187.53 Million -
Net Debt -11.3 Billion -9.71 Billion -9.18 Billion -6.94 Billion -3.93 Billion -4.32 Billion

Balance Sheet Charts